| 2001.5 |
CellSeed Inc. established in Shinjuku-ku, Tokyo with the primary goal of pursuing research and development based on cell sheet engineering |
| 2004.1 |
Sales start for RepCell® temperature-responsive cell cultureware for cell collection and HydroCell® low cell binding cultureware |
| 2007.9 |
Sales start for UpCell® temperature-responsive cell cultureware for cell sheet collection in Japan |
| 2008.2 |
Sales start for temperature-responsive cell cultureware outside Japan |
| 2010.3 |
Currently listed on JASDAQ Growth, Tokyo Stock Exchange |
| 2016.1 |
Head Office moved to Koto-ku, Tokyo (current location) |
| 2016.8 |
Clinical trials begin for epithelial cell sheet for esophageal regeneration in Japan |
| 2017.2 |
Epithelial cell sheet for esophageal regeneration receives Sakigake Designation |
| 2017.3 |
Cell Processing Facility obtains license to manufacuture specified cell products |
| 2017.4 |
Business alliance agreement signed with Taiwan's MetaTech(AP) Inc. |
| 2018.10 |
Gained manufacturing business accreditation for regenerative medicine products |
| 2018.11 |
Commenced regenerative medicine contract service |
| 2020.1 |
Up Cell Biomedical Inc. established in Taiwan |
| 2021.3 |
Transition to a Company with an Audit and Supervisory Committee |
| 2021.9 |
Start of operation of "Aomi Cell Cultureware Innovation Center", a facility for developing and manufacturing new cell culture equipment |
| 2022.4 |
Transferred from JASDAQ Growth, Tokyo Stock Exchange to the Growth Market, Tokyo Stock Exchange due to the reorgnization of the Tokyo Stock Exchange |
| 2023.12 |
Cancellation of business alliance agreement signed with Taiwan's MetaTech(AP) Inc. |
